Showing results (571-580 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|March 25, 2014
Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing tableOliver Kornmann, Henrik Watz, Rainard Fuhr, et al.
Pulmonary Pharmacology & Therapeutics|March 25, 2014
Regulation of pulmonary inflammation by mesenchymal cellsHatem Alkhouri, Wilfred Jelco Poppinga, Navessa Padma Tania, et al.
Pulmonary Pharmacology & Therapeutics|March 6, 2014
Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trialsGuang-Ying Zhuo, Qing He, Li Xiang-Lian, et al.
Pulmonary Pharmacology & Therapeutics|March 5, 2017
The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosisMarina Aiello, Giuseppina Bertorelli, Marialuisa Bocchino, et al.
Pulmonary Pharmacology & Therapeutics|February 25, 2017
Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler® devices in patients with mild to moderate asthma: Appraisal of a four-way crossover designLeif Bjermer, Gail M Gauvreau, Dirkje S Postma, et al.
Pulmonary Pharmacology & Therapeutics|November 20, 2016
A systematic review with meta-analysis of fluticasone furoate/vilanterol combination for the treatment of stable COPDGustavo J Rodrigo, Hugo Neffen
Pulmonary Pharmacology & Therapeutics|February 5, 2017
Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophilsGuy Brusselle, Matthew Germinaro, Sivan Weiss, et al.
Pulmonary Pharmacology & Therapeutics|January 25, 2017
Assessment of the efficacy and safety of fluticasone propionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler versus a multi-dose inhaler in patients with chronic obstructive pulmonary diseaseRobert Chan, Ana R Sousa, Peter Hynds, et al.
Pulmonary Pharmacology & Therapeutics|January 18, 2017
Beta-2-adrenoreceptor polymorphism at position 16 determines the clinical severity of chronic obstructive pulmonary diseaseJustyna Emeryk-Maksymiuk, Andrzej Emeryk, Paweł Krawczyk, et al.
Pulmonary Pharmacology & Therapeutics|January 18, 2017
IL-4R suppresses airway inflammation in bronchial asthma by inhibiting the IL-4/STAT6 pathwayYing Liu, Hui Zhang, Ran Ni, et al.
Pageof 188